Diagnosis of left atrial appendage thrombus using cardiac computed tomography: new insights from thrombi locations
Chuxian Guo,Zhi Jiang,Jionghong He,Haiyan Ma,Yuquan Wang,Jing Tan,Qiaoqiao Ou,Ye Tian,Longhai Tian,Qifang Liu,Jing Huang,Long Yang
DOI: https://doi.org/10.1101/2023.02.24.23286435
2023-01-01
Abstract:Background Cardiac computed tomography (CCT) is an emerging non-invasive modality for assessing left atrial appendage (LAA) thrombus, but the results were conflicting. Our study aims to evaluate the accuracy of CCT for detecting LAA thrombus in patients undergoing catheter ablation of atrial fibrillation (AF), using transesophageal echocardiography (TEE) as the reference standard.
Methods From May 2017 to December 2022, 726 patients (male: 60.2%, age: 61±11 years) who had both TEE and CCT before catheter ablation of AF were retrospectively included. The CCT protocol consisted of one angiographic phase and one delayed scan 30 seconds later. LAA thrombi were defined as solid masses on TEE or persistent defects on CCT. The thrombus dimension and location, the LAA filling and emptying flow velocity were assessed by TEE.
Results Of the 57(7.9%) patients with LAA thrombi identified by TEE, 29(50.9%) were located at the LAA ostium, and 28(49.1%) were in the LAA. The former showed higher motility following blood flow and heartbeats than the latter. The CCT detected 14(48.3%) of the LAA-ostium thrombi but 25(89.3%) of those in the LAA ( p = 0.001). The LAA-ostium thrombi with the LAA mean flow velocity higher than 0.35m/s and maximum diameters shorter than 10mm were more prone to have CCT false-negative results.
Conclusion For patients undergoing catheter ablation for AF, CCT with a 30s delay scan is less sensitive to LAA thrombi than TEE, especially LAA-ostium thrombi with smaller sizes and higher LAA flow velocity.
What are new?
1. Over half of the LAA thrombi were located at the LAA ostium.
2. The CCT was less sensitive to the LAA-ostium thrombi with smaller sizes and higher LAA flow velocity.
What is the clinical implication? 1. The CCT using a 30s delay scan did not reliably exclude the LAA thrombi for the patients scheduled for pulmonary vein isolation, especially those located at the LAA ostium.
### Competing Interest Statement
The authors have declared no competing interest.
### Clinical Trial
The is a retrospective study.
### Funding Statement
This study has received funding from the Science and Technology program of Guizhou Province [No. (2017)2885longyang and (2018)2794tianye], the Clinical Special Projects in Guizhou Province [NO. (2019)4430liuqifang], and the Clinical Research Center Project of the Department of science and technology of Guizhou Province [NO. (2017)5405yanglong]
### Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study was approved by the institutional ethics committee of Guizhou Provincial People's Hospital.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
The data underlying this article may be shared upon reasonable request to the corresponding author.
* AF
: Atrial fibrillation
CCT
: Cardiac computed tomography
CHA2DS2-VASc
: Congestive heart failure, hypertension, age ≥ 75 years (doubled), diabetes, previous stroke/transient ischemic attack/thromboembolism (doubled), vascular disease, age 65–74 years, and sex category (female).
LAA
: Left atrial appendage
LAAMFV
: Left atrial appendage mean flow velocity LAAPD Left atrial anterior-posterior diameter
LVEDD
: Left ventricular end-diastolic diameter
LVEF
: Left ventricular ejection fraction
TEE
: Transesophageal echocardiography
TIA
: Transient ischemic attack